HeartSciences (HSCSW) Accounts Payables (2022 - 2025)

HeartSciences (HSCSW) has reported Accounts Payables for 4 consecutive years, with $318661.0 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Accounts Payables changed N/A year-over-year to $318661.0; the trailing twelve-month figure through Dec 2025 stood at $318661.0 (changed N/A YoY), and the FY2025 full-year result was $318661.0, down 28.9% from the prior year.
• Accounts Payables held at $318661.0 in Q4 2025 per HSCSW's latest filing, from $317390.0 in the prior quarter.
• Across five years, Accounts Payables topped out at $1.1 million in Q4 2023 and bottomed at $276848.0 in Q4 2024.
• Historically, Accounts Payables has averaged $521285.9 across 4 years, with a median of $431629.5 in 2024.
• The sharpest annual moves came in 2023 and 2024: Accounts Payables soared 36.85% in 2023, then sank 74.56% in 2024.
• Over 4 years, Accounts Payables stood at $795266.0 in 2022, then jumped by 36.85% to $1.1 million in 2023, then tumbled by 74.56% to $276848.0 in 2024, then gained by 15.1% to $318661.0 in 2025.
• According to Business Quant data, Accounts Payables over the past three periods registered $318661.0, $317390.0, and $283225.0 for Q4 2025, Q4 2025, and Q3 2025 respectively.